These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
396 related items for PubMed ID: 29937406
1. Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral Envelope Protein. de Wispelaere M, Lian W, Potisopon S, Li PC, Jang J, Ficarro SB, Clark MJ, Zhu X, Kaplan JB, Pitts JD, Wales TE, Wang J, Engen JR, Marto JA, Gray NS, Yang PL. Cell Chem Biol; 2018 Aug 16; 25(8):1006-1016.e8. PubMed ID: 29937406 [Abstract] [Full Text] [Related]
2. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses. Kampmann T, Yennamalli R, Campbell P, Stoermer MJ, Fairlie DP, Kobe B, Young PR. Antiviral Res; 2009 Dec 16; 84(3):234-41. PubMed ID: 19781577 [Abstract] [Full Text] [Related]
3. Small Molecules Targeting the Flavivirus E Protein with Broad-Spectrum Activity and Antiviral Efficacy in Vivo. Li PC, Jang J, Hsia CY, Groomes PV, Lian W, de Wispelaere M, Pitts JD, Wang J, Kwiatkowski N, Gray NS, Yang PL. ACS Infect Dis; 2019 Mar 08; 5(3):460-472. PubMed ID: 30608640 [Abstract] [Full Text] [Related]
4. Discovery of Immunologically Inspired Small Molecules That Target the Viral Envelope Protein. Lian W, Jang J, Potisopon S, Li PC, Rahmeh A, Wang J, Kwiatkowski NP, Gray NS, Yang PL. ACS Infect Dis; 2018 Sep 14; 4(9):1395-1406. PubMed ID: 30027735 [Abstract] [Full Text] [Related]
5. The importance of viral and cellular factors on flavivirus entry. Cordero-Rivera CD, De Jesús-González LA, Osuna-Ramos JF, Palacios-Rápalo SN, Farfan-Morales CN, Reyes-Ruiz JM, Del Ángel RM. Curr Opin Virol; 2021 Aug 14; 49():164-175. PubMed ID: 34171540 [Abstract] [Full Text] [Related]
6. Small molecule inhibitors possibly targeting the rearrangement of Zika virus envelope protein. Sharma N, Prosser O, Kumar P, Tuplin A, Giri R. Antiviral Res; 2020 Oct 14; 182():104876. PubMed ID: 32783901 [Abstract] [Full Text] [Related]
7. Novel approaches to flavivirus drug discovery. Botting C, Kuhn RJ. Expert Opin Drug Discov; 2012 May 14; 7(5):417-28. PubMed ID: 22439769 [Abstract] [Full Text] [Related]
8. Identification of small molecule inhibitors targeting the Zika virus envelope protein. Pitts J, Hsia CY, Lian W, Wang J, Pfeil MP, Kwiatkowski N, Li Z, Jang J, Gray NS, Yang PL. Antiviral Res; 2019 Apr 14; 164():147-153. PubMed ID: 30771406 [Abstract] [Full Text] [Related]
9. Decanoyl-Arg-Val-Lys-Arg-Chloromethylketone: An Antiviral Compound That Acts against Flaviviruses through the Inhibition of Furin-Mediated prM Cleavage. Imran M, Saleemi MK, Chen Z, Wang X, Zhou D, Li Y, Zhao Z, Zheng B, Li Q, Cao S, Ye J. Viruses; 2019 Oct 31; 11(11):. PubMed ID: 31683742 [Abstract] [Full Text] [Related]
10. Two novel compounds inhibit Flavivirus infection in vitro and in vivo by targeting lipid metabolism. Zhou J-f, Zhang M-r, Wang Q, Li M-z, Bai J-s, Dai Q, Zhang Y-h, Yan M-x, Li X-h, Chen J, Liu Y-y, Liu C-c, Ye J, Zhou B. J Virol; 2024 Sep 17; 98(9):e0063524. PubMed ID: 39158346 [Abstract] [Full Text] [Related]
11. Closing the door on flaviviruses: entry as a target for antiviral drug design. Perera R, Khaliq M, Kuhn RJ. Antiviral Res; 2008 Oct 17; 80(1):11-22. PubMed ID: 18585795 [Abstract] [Full Text] [Related]
12. Identification of Zika Virus Inhibitors Using Homology Modeling and Similarity-Based Screening to Target Glycoprotein E. Telehany SM, Humby MS, McGee TD, Riley SP, Jacobs A, Rizzo RC. Biochemistry; 2020 Oct 06; 59(39):3709-3724. PubMed ID: 32876433 [Abstract] [Full Text] [Related]
13. The Antimalarial Compound Atovaquone Inhibits Zika and Dengue Virus Infection by Blocking E Protein-Mediated Membrane Fusion. Yamamoto M, Ichinohe T, Watanabe A, Kobayashi A, Zhang R, Song J, Kawaguchi Y, Matsuda Z, Inoue JI. Viruses; 2020 Dec 21; 12(12):. PubMed ID: 33371476 [Abstract] [Full Text] [Related]
14. Broad-spectrum activity against mosquito-borne flaviviruses achieved by a targeted protein degradation mechanism. Liu HY, Li Z, Reindl T, He Z, Qiu X, Golden RP, Donovan KA, Bailey A, Fischer ES, Zhang T, Gray NS, Yang PL. Nat Commun; 2024 Jun 19; 15(1):5179. PubMed ID: 38898037 [Abstract] [Full Text] [Related]
15. Establishment of Baculovirus-Expressed VLPs Induced Syncytial Formation Assay for Flavivirus Antiviral Screening. Dai S, Zhang Y, Zhang T, Zhang B, Wang H, Deng F. Viruses; 2018 Jul 11; 10(7):. PubMed ID: 29997331 [Abstract] [Full Text] [Related]
16. A small molecule fusion inhibitor of dengue virus. Poh MK, Yip A, Zhang S, Priestle JP, Ma NL, Smit JM, Wilschut J, Shi PY, Wenk MR, Schul W. Antiviral Res; 2009 Dec 11; 84(3):260-6. PubMed ID: 19800368 [Abstract] [Full Text] [Related]
17. A novel flavivirus entry inhibitor, BP34610, discovered through high-throughput screening with dengue reporter viruses. Yang CC, Hu HS, Lin HM, Wu PS, Wu RH, Tian JN, Wu SH, Tsou LK, Song JS, Chen HW, Chern JH, Chen CT, Yueh A. Antiviral Res; 2019 Dec 11; 172():104636. PubMed ID: 31654671 [Abstract] [Full Text] [Related]
18. Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond. Boldescu V, Behnam MAM, Vasilakis N, Klein CD. Nat Rev Drug Discov; 2017 Aug 11; 16(8):565-586. PubMed ID: 28473729 [Abstract] [Full Text] [Related]
19. Arbidol (Umifenovir): A Broad-Spectrum Antiviral Drug That Inhibits Medically Important Arthropod-Borne Flaviviruses. Haviernik J, Štefánik M, Fojtíková M, Kali S, Tordo N, Rudolf I, Hubálek Z, Eyer L, Ruzek D. Viruses; 2018 Apr 10; 10(4):. PubMed ID: 29642580 [Abstract] [Full Text] [Related]